» Articles » PMID: 22645396

Tobacco Smoking Among People Living with a Psychotic Illness: the Second Australian Survey of Psychosis

Overview
Specialty Psychiatry
Date 2012 May 31
PMID 22645396
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aims of this study were to (a) describe patterns of tobacco smoking among Australians living with a psychotic illness and (b) explore the association between smoking and measures of psychopathology, psychiatric history, psychosocial functioning, physical health, substance use and demographic characteristics.

Methods: Data were from 1812 participants in the 2010 Australian Survey of High Impact Psychosis. Participants were aged 18-64 years and resided in seven mental health catchment sites across five states of Australia. Bivariate statistics were used to compare smokers with non-smokers on the measures of interest, and to compare ICD-10 diagnostic categories on measures of smoking prevalence, nicotine addiction and quitting history. Multivariate logistic regression was used to test whether (a) demographics and psychiatric history were associated with having ever smoked and (b) whether symptoms and psychosocial functioning were independently associated with current smoking, after controlling for demographics, psychiatric history and substance use.

Results: The prevalence of current tobacco smoking was 66.6% (72% of men and 59% of women); lifetime prevalence was 81%. In univariate analyses, individuals with a diagnosis of schizophrenia or schizoaffective disorder were most likely to be smoking tobacco (70%) and were more nicotine dependent. Smokers reported worse perceived physical health, lower body mass index and waist circumference, and more lifetime medical conditions. A younger age of illness onset, male gender and low education were associated with having ever smoked. Associations with current smoking included low education, male gender, no formal employment, worse negative symptoms, higher daily caffeine consumption, and alcohol dependence and substance abuse/dependence.

Conclusions: The prevalence of tobacco smoking is high amongst people with a psychotic disorder, and is associated with adverse mental health symptoms as well as high rates of other substance use, poorer subjective physical health, and a higher risk of the many known health consequences of smoking.

Citing Articles

Interventions for smoking cessation in inpatient psychiatry settings.

Plever S, Kisely S, Bonevski B, Siskind D, Guillaumier A, McCarter K Cochrane Database Syst Rev. 2024; 9:CD015934.

PMID: 39229858 PMC: 11372853. DOI: 10.1002/14651858.CD015934.


Effectiveness of Culinary Nutrition Workshops on the Mood and Nutritional Interest of Inpatients With Mental Disorder.

Vaque-Crusellas C, Ribot B, Corominas-Diaz A, Prat-Vigue G, Vila-Marti A, Torres-Moreno M Cureus. 2024; 16(7):e64691.

PMID: 39156399 PMC: 11327369. DOI: 10.7759/cureus.64691.


Smoking affects symptom improvement in schizophrenia: a prospective longitudinal study of male patients with first-episode schizophrenia.

Mu X, Wu W, Wang S, Su X, Guan H, Guan X Schizophrenia (Heidelb). 2024; 10(1):34.

PMID: 38491003 PMC: 10943037. DOI: 10.1038/s41537-024-00449-1.


Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study.

Gao Z, Xiu M, Liu J, Wu F, Zhang X Curr Neuropharmacol. 2023; 22(10):1733-1741.

PMID: 37859307 PMC: 11284715. DOI: 10.2174/1570159X22666231019105328.


Prevalence of High-dose Antipsychotic Prescribing in Schizophrenia: A Clinical Audit in a Regional Queensland Mental Health Service.

Luthra S, Duggan L, Agrawal A, Kaur G, Luthra N Int J Appl Basic Med Res. 2023; 13(2):70-76.

PMID: 37614838 PMC: 10443448. DOI: 10.4103/ijabmr.ijabmr_504_22.